{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:47:27Z","timestamp":1793850447368,"version":"4.6.1"},"reference-count":62,"publisher":"American Society of Hematology","issue":"17","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The fusion gene MLL\/AF4 defines a high-risk subtype of pro-B acute lymphoblastic leukemia. Relapse can be associated with a lineage switch from acute lymphoblastic to acute myeloid leukemia, resulting in poor clinical outcomes caused by resistance to chemotherapies and immunotherapies. In this study, the myeloid relapses shared oncogene fusion breakpoints with their matched lymphoid presentations and originated from various differentiation stages from immature progenitors through to committed B-cell precursors. Lineage switching is linked to substantial changes in chromatin accessibility and rewiring of transcriptional programs, including alternative splicing. These findings indicate that the execution and maintenance of lymphoid lineage differentiation is impaired. The relapsed myeloid phenotype is recurrently associated with the altered expression, splicing, or mutation of chromatin modifiers, including CHD4 coding for the ATPase\/helicase of the nucleosome remodelling and deacetylation complex. Perturbation of CHD4 alone or in combination with other mutated epigenetic modifiers induces myeloid gene expression in MLL\/AF4+ cell models, indicating that lineage switching in MLL\/AF4 leukemia is driven and maintained by disrupted epigenetic regulation.<\/jats:p>","DOI":"10.1182\/blood.2021015036","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T16:16:41Z","timestamp":1657901801000},"page":"1875-1890","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":78,"title":["Epigenetic regulator genes direct lineage switching in\u00a0\n                    <i>MLL\/AF4<\/i>\n                    leukemia"],"prefix":"10.1182","volume":"140","author":[{"given":"Ricky","family":"Tirtakusuma","sequence":"first","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-5221","authenticated-orcid":false,"given":"Katarzyna","family":"Szoltysek","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"2Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"3Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-0463","authenticated-orcid":false,"given":"Paul","family":"Milne","sequence":"additional","affiliation":[{"name":"4Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-7333","authenticated-orcid":false,"given":"Vasily V.","family":"Grinev","sequence":"additional","affiliation":[{"name":"5Department of Genetics, the Faculty of Biology, Belarusian State University, Minsk, Republic of Belarus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Ptasinska","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1600-3508","authenticated-orcid":false,"given":"Paulynn S.","family":"Chin","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Meyer","sequence":"additional","affiliation":[{"name":"7Institute of Pharmaceutical Biology\/DCAL, Goethe-University, Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirintra","family":"Nakjang","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0837-304X","authenticated-orcid":false,"given":"Jayne Y.","family":"Hehir-Kwa","sequence":"additional","affiliation":[{"name":"2Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Williamson","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cauchy","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Keane","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salam A.","family":"Assi","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-363X","authenticated-orcid":false,"given":"Minoo","family":"Ashtiani","sequence":"additional","affiliation":[{"name":"2Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-7460","authenticated-orcid":false,"given":"Sophie G.","family":"Kellaway","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Imperato","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Vogiatzi","sequence":"additional","affiliation":[{"name":"8ALL-BFM Study Group, Pediatric Hematology\/Oncology, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Schweighart","sequence":"additional","affiliation":[{"name":"2Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lin","sequence":"additional","affiliation":[{"name":"9Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wunderlich","sequence":"additional","affiliation":[{"name":"9Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Stutterheim","sequence":"additional","affiliation":[{"name":"2Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9113-698X","authenticated-orcid":false,"given":"Alexander","family":"Komkov","sequence":"additional","affiliation":[{"name":"10Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-5828","authenticated-orcid":false,"given":"Elena","family":"Zerkalenkova","sequence":"additional","affiliation":[{"name":"10Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Evans","sequence":"additional","affiliation":[{"name":"11Haematological Malignancy Diagnostic Service, St James\u2019s University Hospital, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesta","family":"McNeill","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Elder","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Martinez-Soria","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3778-8634","authenticated-orcid":false,"given":"Sarah E.","family":"Fordham","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Shi","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Russell","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Pal","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Smith","sequence":"additional","affiliation":[{"name":"12Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Kingsbury","sequence":"additional","affiliation":[{"name":"13Illumina Cambridge Ltd., Great Abington, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Becq","sequence":"additional","affiliation":[{"name":"13Illumina Cambridge Ltd., Great Abington, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Eckert","sequence":"additional","affiliation":[{"name":"14Department of Pediatric Oncology\/Hematology, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar A.","family":"Haas","sequence":"additional","affiliation":[{"name":"15St Anna Children\u2019s Cancer Research Institute (CCRI), Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Carey","sequence":"additional","affiliation":[{"name":"16Department of Paediatric Haematology and Oncology, The Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bailey","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"16Department of Paediatric Haematology and Oncology, The Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-675X","authenticated-orcid":false,"given":"Roderick","family":"Skinner","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"16Department of Paediatric Haematology and Oncology, The Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Miakova","sequence":"additional","affiliation":[{"name":"10Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Collin","sequence":"additional","affiliation":[{"name":"4Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3017-2474","authenticated-orcid":false,"given":"Venetia","family":"Bigley","sequence":"additional","affiliation":[{"name":"4Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzlifah","family":"Haniffa","sequence":"additional","affiliation":[{"name":"17Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"18Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom"},{"name":"19Department of Dermatology and Newcastle National Institute of Health Research (NIHR), Newcastle Biomedical Research Centre, Newcastle Hospitals National Health Service (NHS) Foundation Trust, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-3445","authenticated-orcid":false,"given":"Rolf","family":"Marschalek","sequence":"additional","affiliation":[{"name":"7Institute of Pharmaceutical Biology\/DCAL, Goethe-University, Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Cargo","sequence":"additional","affiliation":[{"name":"11Haematological Malignancy Diagnostic Service, St James\u2019s University Hospital, Leeds, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Schewe","sequence":"additional","affiliation":[{"name":"20Department of Pediatrics, Otto von Guericke University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2352-7716","authenticated-orcid":false,"given":"Yulia","family":"Olshanskaya","sequence":"additional","affiliation":[{"name":"10Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Thirman","sequence":"additional","affiliation":[{"name":"21Department of Medicine, Section of Hematology\/Oncology, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-8174","authenticated-orcid":false,"given":"Peter N.","family":"Cockerill","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Mulloy","sequence":"additional","affiliation":[{"name":"9Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Blair","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vormoor","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"2Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Allan","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Bonifer","sequence":"additional","affiliation":[{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-6483","authenticated-orcid":false,"given":"Olaf","family":"Heidenreich","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"2Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-5738","authenticated-orcid":false,"given":"Simon","family":"Bomken","sequence":"additional","affiliation":[{"name":"1Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"},{"name":"16Department of Paediatric Haematology and Oncology, The Great North Children\u2019s Hospital, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2022102715264462700_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"issue":"5","key":"2022102715264462700_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5 suppl","key":"2022102715264462700_bib3","first-page":"ECR09","article-title":"Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia","volume":"91","author":"Germano","year":"2006","journal-title":"Haematologica"},{"issue":"8","key":"2022102715264462700_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/10428190500086055","article-title":"Congenital MLL-positive B-cell acute lymphoblastic leukemia (B-ALL) switched lineage at relapse to acute myelocytic leukemia (AML) with persistent t(4;11) and t(1;6) translocations and JH gene rearrangement","volume":"46","author":"Jiang","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2022102715264462700_bib5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajh.23266","article-title":"Lineage switch in childhood acute leukemia: an unusual event with poor outcome","volume":"87","author":"Rossi","year":"2012","journal-title":"Am J Hematol"},{"issue":"7727","key":"2022102715264462700_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"1","key":"2022102715264462700_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-cancerbio-030617-050224","article-title":"Lineage plasticity in cancer progression and treatment","volume":"2","author":"Le Magnen","year":"2018","journal-title":"Annu Rev Cancer Biol"},{"issue":"6","key":"2022102715264462700_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"6204","key":"2022102715264462700_bib9","doi-asserted-by":"crossref","first-page":"1251033","DOI":"10.1126\/science.1251033","article-title":"Transcriptional diversity during lineage commitment of human blood progenitors","volume":"345","author":"Chen","year":"2014","journal-title":"Science"},{"issue":"4","key":"2022102715264462700_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"2022102715264462700_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2011.01.004","article-title":"Densely interconnected transcriptional circuits control cell states in human hematopoiesis","volume":"144","author":"Novershtern","year":"2011","journal-title":"Cell"},{"issue":"1","key":"2022102715264462700_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1755-8794-2-36","article-title":"MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures","volume":"2","author":"Zangrando","year":"2009","journal-title":"BMC Med Genomics"},{"issue":"10","key":"2022102715264462700_bib13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/leu.2010.155","article-title":"Leukemic fusion genes MLL\/AF4 and AML1\/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT","volume":"24","author":"Gessner","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"2022102715264462700_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","article-title":"Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells","volume":"4","author":"Somervaille","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2022102715264462700_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.celrep.2012.12.016","article-title":"RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction","volume":"3","author":"Wilkinson","year":"2013","journal-title":"Cell Rep"},{"issue":"21","key":"2022102715264462700_bib16","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1093\/nar\/gkt850","article-title":"Wellington: a novel method for the accurate identification of digital genomic footprints from DNase-seq data","volume":"41","author":"Piper","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2022102715264462700_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trecan.2015.10.003","article-title":"Chromatin structure profiling identifies crucial regulators of tumor maintenance","volume":"1","author":"Bonifer","year":"2015","journal-title":"Trends Cancer"},{"issue":"42","key":"2022102715264462700_bib18","doi-asserted-by":"crossref","first-page":"E4513","DOI":"10.1073\/pnas.1406985111","article-title":"Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma","volume":"111","author":"Kreher","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21-22","key":"2022102715264462700_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1101\/gad.348738.121","article-title":"Efficient hemogenic endothelial cell specification by RUNX1 is dependent on baseline chromatin accessibility of RUNX1-regulated TGF\u03b2 target genes","volume":"35","author":"Howell","year":"2021","journal-title":"Genes Dev"},{"issue":"10","key":"2022102715264462700_bib20","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1128\/MCB.15.10.5830","article-title":"PU.1 (Spi-1) and C\/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene","volume":"15","author":"Hohaus","year":"1995","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2022102715264462700_bib21","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood-2010-08-302976","article-title":"Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells","volume":"117","author":"Leddin","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2022102715264462700_bib22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/gcc.22090","article-title":"The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia","volume":"52","author":"Dobbins","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"2022102715264462700_bib23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3324\/haematol.2018.206375","article-title":"Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis","volume":"104","author":"Agraz-Doblas","year":"2019","journal-title":"Haematologica"},{"issue":"22","key":"2022102715264462700_bib24","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1073\/pnas.1821301116","article-title":"CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesis","volume":"116","author":"Arends","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2022102715264462700_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2009.01.014","article-title":"Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells","volume":"30","author":"Ng","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"2022102715264462700_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ni.2150","article-title":"Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis","volume":"13","author":"Zhang","year":"2011","journal-title":"Nat Immunol"},{"issue":"7696","key":"2022102715264462700_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature25795","article-title":"Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours","volume":"555","author":"Ma","year":"2018","journal-title":"Nature"},{"issue":"4","key":"2022102715264462700_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajhg.2011.03.004","article-title":"Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel","volume":"88","author":"Gonz\u00e1lez-P\u00e9rez","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"9","key":"2022102715264462700_bib29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng.3627","article-title":"Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing","volume":"48","author":"Sifrim","year":"2016","journal-title":"Nat Genet"},{"key":"2022102715264462700_bib30","doi-asserted-by":"crossref","first-page":"633233","DOI":"10.3389\/fonc.2021.633233","article-title":"Role of chromodomain-helicase-DNA-binding protein 4 (CHD4) in breast cancer","volume":"11","author":"Novillo","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"2022102715264462700_bib31","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1038\/s41467-021-26360-2","article-title":"PHF3 regulates neuronal gene expression through the Pol II CTD reader domain SPOC","volume":"12","author":"Appel","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"2022102715264462700_bib32","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2009-05-218560","article-title":"Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia","volume":"115","author":"Kang","year":"2010","journal-title":"Blood"},{"issue":"24","key":"2022102715264462700_bib33","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1001\/jama.2010.1862","article-title":"Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia","volume":"304","author":"Gentles","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"2022102715264462700_bib34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3324\/haematol.12221","article-title":"Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia","volume":"93","author":"Ferreira","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"2022102715264462700_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccell.2016.10.008","article-title":"Instructive role of MLL-fusion proteins revealed by a model of t(4;11) pro-B acute lymphoblastic leukemia","volume":"30","author":"Lin","year":"2016","journal-title":"Cancer Cell"},{"issue":"10","key":"2022102715264462700_bib36","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nbt.3979","article-title":"Antigen receptor repertoire profiling from RNA-seq data","volume":"35","author":"Bolotin","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2022102715264462700_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccr.2008.05.015","article-title":"In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties","volume":"14","author":"le Viseur","year":"2008","journal-title":"Cancer Cell"},{"issue":"12","key":"2022102715264462700_bib38","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.3324\/haematol.2018.191718","article-title":"The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of\u00a0t(4;11) MLL-AF4 infant leukemia","volume":"103","author":"Malouf","year":"2018","journal-title":"Haematologica"},{"issue":"4","key":"2022102715264462700_bib39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41591-022-01720-7","article-title":"Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia","volume":"28","author":"Khabirova","year":"2022","journal-title":"Nat Med"},{"issue":"6753","key":"2022102715264462700_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/44076","article-title":"Commitment to the B-lymphoid lineage depends on the transcription factor Pax5","volume":"401","author":"Nutt","year":"1999","journal-title":"Nature"},{"issue":"9","key":"2022102715264462700_bib41","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.leu.2404808","article-title":"Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias","volume":"21","author":"Mullighan","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"2022102715264462700_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/leu.2015.199","article-title":"Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study","volume":"30","author":"Boer","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"2022102715264462700_bib43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1084\/jem.20160048","article-title":"Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome","volume":"214","author":"Witkowski","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"2022102715264462700_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ni1555","article-title":"Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5","volume":"9","author":"Pongubala","year":"2008","journal-title":"Nat Immunol"},{"issue":"2","key":"2022102715264462700_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.stemcr.2015.06.007","article-title":"C\/EBP\u03b1 activates pre-existing and de novo macrophage enhancers during induced pre-B cell transdifferentiation and myelopoiesis","volume":"5","author":"van Oevelen","year":"2015","journal-title":"Stem Cell Reports"},{"issue":"9","key":"2022102715264462700_bib46","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1101\/gad.1642808","article-title":"The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation","volume":"22","author":"Yoshida","year":"2008","journal-title":"Genes Dev"},{"issue":"2","key":"2022102715264462700_bib47","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.celrep.2019.06.029","article-title":"MTA2\/NuRD regulates B cell development and cooperates with OCA-B in controlling the pre-B to immature B cell transition","volume":"28","author":"Lu","year":"2019","journal-title":"Cell Rep"},{"issue":"12","key":"2022102715264462700_bib48","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1182\/blood-2015-03-631606","article-title":"Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation","volume":"126","author":"Sperlazza","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2022102715264462700_bib49","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3324\/haematol.2017.183970","article-title":"The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia","volume":"103","author":"Heshmati","year":"2018","journal-title":"Haematologica"},{"issue":"3","key":"2022102715264462700_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2018.07.004","article-title":"Neutralizing Gatad2a-Chd4-Mbd3\/NuRD complex facilitates deterministic induction of naive pluripotency","volume":"23","author":"Mor","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2022102715264462700_bib51","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.celrep.2016.12.054","article-title":"MLL-AF4 spreading identifies binding sites that are distinct from super-enhancers and that govern sensitivity to DOT1L inhibition in leukemia","volume":"18","author":"Kerry","year":"2017","journal-title":"Cell Rep"},{"issue":"7","key":"2022102715264462700_bib52","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1101\/gr.268490.120","article-title":"A\u00a0KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes","volume":"31","author":"Harman","year":"2021","journal-title":"Genome Res"},{"issue":"5","key":"2022102715264462700_bib53","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol Cell"},{"issue":"1","key":"2022102715264462700_bib54","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1038\/ncomms12320","article-title":"CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity","volume":"7","author":"Jacoby","year":"2016","journal-title":"Nat Commun"},{"issue":"20","key":"2022102715264462700_bib55","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","article-title":"Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy","volume":"127","author":"Gardner","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2022102715264462700_bib56","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/pbc.25953","article-title":"Lineage switch in MLL-rearranged infant leukemia following CD19-directed therapy","volume":"63","author":"Rayes","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2022102715264462700_bib57","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","article-title":"Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy","volume":"5","author":"Sotillo","year":"2015","journal-title":"Cancer Discov"},{"issue":"1","key":"2022102715264462700_bib58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41467-021-21168-6","article-title":"Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy","volume":"12","author":"Rabilloud","year":"2021","journal-title":"Nat Commun"},{"issue":"7750","key":"2022102715264462700_bib59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1054-1","article-title":"CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape","volume":"568","author":"Hamieh","year":"2019","journal-title":"Nature"},{"key":"2022102715264462700_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2021.07.002","article-title":"Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia","volume":"100","author":"Liao","year":"2021","journal-title":"Exp Hematol"},{"issue":"suppl_1","key":"2022102715264462700_bib61","article-title":"KMT2A rearrangements are associated with lineage switch following CD19 targeting CAR T-cell therapy","volume":"138","author":"Lamble","year":"2021","journal-title":"Blood"},{"issue":"14","key":"2022102715264462700_bib62","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood.2021012727","article-title":"Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy","volume":"139","author":"Leahy","year":"2022","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/17\/1875\/1927378\/blood_bld-2021-015036-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/17\/1875\/1927378\/blood_bld-2021-015036-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T11:30:02Z","timestamp":1666870202000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/17\/1875\/485936\/Epigenetic-regulator-genes-direct-lineage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":62,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021015036","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.16.452676","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}